RACHEL CROWDER: Open Payments
NPI 1578326757 · GRESHAM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $502
Food & beverage: $469Education: $33
| Company | Payments | Amount |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | 1 | $150 |
| Janssen Biotech, Inc. | 2 | $142 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Amgen Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| TerSera Therapeutics LLC | 1 | $25 |
Products named: PYLARIFY, RYBREVANT, ENHERTU, OJJAARA, Zoladex, TECVAYLI.
Industry payments across OR — which companies pay providers there.
